Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 21% ± 4% | |
endothelial cell | 3 studies | 18% ± 2% | |
GABAergic neuron | 3 studies | 29% ± 4% | |
glutamatergic neuron | 3 studies | 38% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1763.76 | 1445 / 1445 | 100% | 16.02 | 183 / 183 |
brain | 100% | 1659.44 | 2641 / 2642 | 100% | 16.20 | 705 / 705 |
prostate | 100% | 1594.94 | 245 / 245 | 100% | 14.04 | 501 / 502 |
lung | 100% | 1346.72 | 577 / 578 | 100% | 12.74 | 1154 / 1155 |
breast | 100% | 1587.17 | 459 / 459 | 100% | 16.42 | 1115 / 1118 |
ovary | 100% | 2026.94 | 180 / 180 | 99% | 9.45 | 427 / 430 |
uterus | 100% | 1664.42 | 170 / 170 | 99% | 12.30 | 455 / 459 |
intestine | 100% | 1781.89 | 966 / 966 | 99% | 12.73 | 522 / 527 |
thymus | 100% | 1461.33 | 653 / 653 | 99% | 12.74 | 599 / 605 |
stomach | 100% | 1182.61 | 359 / 359 | 99% | 12.37 | 283 / 286 |
bladder | 100% | 1876.29 | 21 / 21 | 99% | 11.08 | 497 / 504 |
pancreas | 100% | 951.13 | 327 / 328 | 99% | 11.58 | 176 / 178 |
kidney | 100% | 1394.71 | 89 / 89 | 97% | 12.20 | 874 / 901 |
liver | 100% | 1267.34 | 226 / 226 | 97% | 8.38 | 392 / 406 |
skin | 100% | 1932.18 | 1808 / 1809 | 95% | 12.59 | 448 / 472 |
adrenal gland | 100% | 1467.48 | 258 / 258 | 93% | 10.49 | 215 / 230 |
adipose | 100% | 1587.68 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1672.52 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 10.15 | 29 / 29 |
muscle | 100% | 3498.72 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1410.56 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.22 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.19 | 1 / 1 |
heart | 98% | 1432.74 | 845 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 83% | 7.22 | 66 / 80 |
peripheral blood | 47% | 559.07 | 435 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0050821 | Biological process | protein stabilization |
GO_0005829 | Cellular component | cytosol |
GO_0031417 | Cellular component | NatC complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004596 | Molecular function | peptide alpha-N-acetyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NAA30 |
Protein name | N-alpha-acetyltransferase 30, NatC catalytic subunit N-alpha-acetyltransferase 30 (EC 2.3.1.256) (N-acetyltransferase 12) (N-acetyltransferase MAK3 homolog) (NatC catalytic subunit) N-acetyltransferase 12, isoform CRA_a (N-alpha-acetyltransferase 30, NatC catalytic subunit) (cDNA FLJ50785) |
Synonyms | C14orf35 hCG_1817074 MAK3 NAT12 |
Description | FUNCTION: Catalytic subunit of the N-terminal acetyltransferase C (NatC) complex. Catalyzes acetylation of the N-terminal methionine residues of peptides beginning with Met-Leu-Ala and Met-Leu-Gly. Necessary for the lysosomal localization and function of ARL8B sugeesting that ARL8B is a NatC substrate. . |
Accessions | G3V3I2 ENST00000554703.1 Q147X3 B4DK34 ENST00000555166.5 J3KNC2 ENST00000298406.6 ENST00000556492.6 [Q147X3-1] |